MDXH vs. OPGN, BGLC, ACON, FRES, NTRA, LH, DGX, EXAS, RDNT, and GH
Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include OpGen (OPGN), BioNexus Gene Lab (BGLC), Aclarion (ACON), Fresh2 Group (FRES), Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), and Guardant Health (GH). These companies are all part of the "medical laboratories" industry.
MDxHealth vs.
MDxHealth (NASDAQ:MDXH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.
MDxHealth has a net margin of -49.52% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat MDxHealth's return on equity.
OpGen received 286 more outperform votes than MDxHealth when rated by MarketBeat users. However, 55.56% of users gave MDxHealth an outperform vote while only 53.18% of users gave OpGen an outperform vote.
MDxHealth has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, OpGen has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500.
MDxHealth currently has a consensus target price of $7.00, indicating a potential upside of 251.76%. Given MDxHealth's stronger consensus rating and higher possible upside, equities research analysts plainly believe MDxHealth is more favorable than OpGen.
OpGen has lower revenue, but higher earnings than MDxHealth.
In the previous week, MDxHealth and MDxHealth both had 1 articles in the media. MDxHealth's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score.
2.7% of OpGen shares are held by institutional investors. 1.7% of MDxHealth shares are held by company insiders. Comparatively, 43.8% of OpGen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
MDxHealth beats OpGen on 8 of the 13 factors compared between the two stocks.
Get MDxHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
MDxHealth Competitors List
Related Companies and Tools
This page (NASDAQ:MDXH) was last updated on 1/22/2025 by MarketBeat.com Staff